Marshall Fordyce, President and CEO at Vera Therapeutics, Inc. (VERA), sold 58,044 shares at $21.07 ($1.2M) on 2022-09-12, disclosed to the SEC on 2022-09-13.
Open-market sale of $1.2M VERA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.16 | 12,886 | $260K | 21.9% |
| 2 | $20.16 | 12,886 | $260K | 21.9% |
| 3 | $20.53 | 12,821 | $263K | 22.2% |
| 4 | $20.53 | 12,821 | $263K | 22.2% |
| 5 | $21.07 | 3,315 | $70K | 5.9% |
| 6 | $21.07 | 3,315 |
| $70K |
| 5.9% |
| Total | $20.43 avg | 58,044 | $1.2M | 100% |
| Filing → |
| VERA | SELL | 2026-07-09 | $2.0M | — | Filing → |
| VERA | SELL | 2026-06-24 | $702K | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |